未登录.png)
分享.png)
收藏Analysis of SARS-CoV-2 antibody seroprevalence in Northern Ireland during 2020-2021
Greene, Michelle K.; Smyth, Peter; English, Andrew; McLaughlin, Joseph; Bucholc, Magda; Bailie, Janice; McCarroll, Julie; McDonnell, Margaret; Watt, Alison; Barnes, George; Lynch, Mark; Duffin, Kevan; Duffy, Gerard; Lewis, Claire; James, Jacqueline A.; Stitt, Alan W.; Ford, Tom; O'Kane, Maurice; Rai, Taranjit Singh; Bjourson, Anthony J.; Cardwell, Christopher; Elborn, J. Stuart; Gibson, David S.; Scott, Christopher J. 分享 收藏 分享 收藏 分享 收藏 Regulation of transforming growth factor α expression in a growth factor-independent cell lineHowell, GM; Humphrey, LE; Ziober, BL; Awwad, R; Periyasamy, B; Koterba, A; Li, WH; Willson, JKV; Coleman, K; Carboni, J; Lynch, M; Brattain, MG 分享 收藏 Microfluidic live tracking and transcriptomics of cancer-immune cell doublets link intercellular proximity and gene regulationFlores, Bianca C. T.; Chawla, Smriti; Ma, Ning; Sanada, Chad; Kujur, Praveen Kumar; Yeung, Rudy; Bellon, Margot B.; Hukari, Kyle; Fowler, Brian; Lynch, Mark; Chinen, Ludmilla T. D.; Ramalingam, Naveen; Sengupta, Debarka; Jeffrey, Stefanie S. 分享 收藏 分享 收藏 Chemotherapy induces canalization of cell state in childhood B-cell precursor acute lymphoblastic leukemiaTurati, Virginia A.; Guerra-Assuncao, Jose Afonso; Potter, Nicola E.; Gupta, Rajeev; Ecker, Simone; Daneviciute, Agne; Tarabichi, Maxime; Webster, Amy P.; Ding, Chuling; May, Gillian; James, Chela; Brown, John; Conde, Lucia; Russell, Lisa J.; Ancliff, Phil; Inglott, Sarah; Cazzaniga, Giovanni; Biondi, Andrea; Hall, Georgina W.; Lynch, Mark; Hubank, Mike; Macaulay, Iain; Beck, Stephan; Van Loo, Peter; Jacobsen, Sten E.; Greaves, Mel; Herrero, Javier; Enver, Tariq 分享 收藏 分享 收藏 分享 收藏 分享 收藏 Full-Length mRNA transcriptome analysis of matched circulating tumor and immune cells from breast cancer subjectsRamalingam, Naveen; Lee, Yifang; Szpankowski, Lukasz; Leyrat, Anne; Fowler, Brian; Delos Angeles, Ninez; Sanada, Chad; Wu, Andrew; Yap, Yoon Sim; West, Jay; Bhagat, Ali Asgar; Hukari, Kyle; Lynch, Mark; King, David 分享 收藏 Nivolumab treatment beyond RECIST-defined progression in recurrent or metastatic squamous cell carcinoma of the head and neck in CheckMate 141: A subgroup analysis of a randomized phase 3 clinical trialHaddad, Robert; Concha-Benavente, Fernando; Blumenschein, George, Jr.; Fayette, Jerome; Guigay, Joel; Colevas, A. Dimitrios; Licitra, Lisa; Kasper, Stefan; Vokes, Everett E.; Worden, Francis; Saba, Nabil F.; Tahara, Makoto; Jayaprakash, Vijayvel; Lynch, Mark; Li, Li; Gillison, Maura L.; Harrington, Kevin J.; Ferris, Robert L. 分享 收藏 分享 收藏 Nivolumab (Nivo) vs investigator's choice (IC) in recurrent or metastatic (R/M) squamous cell carcinoma of the head and neck (SCCHN): 2-yr outcomes in the overall population and PD-L1 subgroups of CheckMate 141Ferris, Robert L.; Blumenschein, George R.; Fayette, Jerome; Guigay, Joel; Colevas, A. Dimitrios; Licitra, Lisa; Harrington, Kevin J.; Kasper, Stefan; Vokes, Everett E.; Even, Caroline; Worden, Francis; Saba, Nabil F.; Docampo, Lara Carmen Iglesias; Haddad, Robert; Rordorf, Tamara; Kiyota, Naomi; Tahara, Makoto; Lynch, Mark; Jayaprakash, Vijayvel; Li, Li; Gillison, Maura L. 分享 收藏 Nivolumab vs investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck: 2-year long-term survival update of CheckMate 141 with analyses by tumor PD-L1 expressionNivolumab与研究者在复发或转移性头颈部鳞状细胞癌中的选择: 通过肿瘤PD-L1表达分析CheckMate 141的2年长期生存更新Ferris, Robert L.; Blumenschein, George, Jr.; Fayette, Jerome; Guigay, Joel; Colevas, A. Dimitrios; Licitra, Lisa; Harrington, Kevin J.; Kasper, Stefan; Vokes, Everett E.; Even, Caroline; Worden, Francis; Saba, Nabil F.; Iglesias Docampo, Lara Carmen; Haddad, Robert; Rordorf, Tamara; Kiyota, Naomi; Tahara, Makoto; Lynch, Mark; Jayaprakash, Vijayvel; Li, Li; Gillison, Maura L. 分享 收藏 Two-year Update From CheckMate 141: Outcomes With Nivolumab (Nivo) vs Investigator's Choice (IC) in Recurrent or Metastatic (R/M) Squamous Cell Carcinoma of the Head and Neck (SCCHN) in the Overall Population and PD-L1 SubgroupsFerris, R. L.; Blumenschein, G. R.; Fayette, J.; Guigay, J.; Colevas, A. D.; Licitra, L.; Harrington, K.; Kasper, S.; Vokes, E. E.; Even, C.; Worden, F.; Saba, N. F.; Docampo, LCIglesias; Haddad, R. I.; Rordorf, T.; Kiyota, N.; Tahara, M.; Lynch, M.; Li, L.; Gillison, M. 分享 收藏 A randomized, open-label, Phase III clinical trial of nivolumab vs. therapy of investigator's choice in recurrent squamous cell carcinoma of the head and neck: A subanalysis of Asian patients versus the global population in checkmate 141Kiyota, Naomi; Hasegawa, Yasuhisa; Takahashi, Shunji; Yokota, Tomoya; Yen, Chia-Jui; Iwae, Shigemichi; Shimizu, Yasushi; Hong, Ruey-Long; Goto, Masahiro; Kang, Jin-Hyoung; Li, Wing Sum Kenneth; Ferris, Robert L.; Gillison, Maura; Namba, Yoshinobu; Monga, Manish; Lynch, Mark; Tahara, Makoto 分享 收藏 Treatment beyond progression with nivolumab in patients with recurrent or metastatic squamous cell carcinoma of the head and neck in the phase 3 Checkmate 141 studyHaddad, Robert; Ferris, Robert L.; Blumenschein, George; Fayette, Jerome; Guigay, Joel; Colevas, Alexander D.; Licitra, Lisa; Kasper, Stefan; Vokes, Everett E.; Worden, Francis; Saba, Nabil F.; Tahara, Makoto; Monga, Manish; Lynch, Mark; Zhu, Jin; Shaw, James W.; Gillison, Maura L.; Harrington, Kevin 分享 收藏 Evaluation of oral microbiome profiling as a response biomarker in squamous cell carcinoma of the head and neck: Analyses from CheckMate 141Ferris, Robert L.; Blumenschein, George; Harrington, Kevin; Fayette, Jerome; Guigay, Joel; Colevas, A. Dimitrios; Licitra, Lisa; Vokes, Everett; Gillison, Maura; Even, Caroline; Ho, Cheryl; Tahara, Makoto; Haddad, Robert; Lynch, Mark; Monga, Manish; Bandyopadhyay, Somnath; Jabado, Omar; Kao, Henry 分享 收藏 
.png){kind=icon}
.png){kind=icon}
.png)
AQUACULTURE.png)
